Living Cell Technologies Ltd. (AU:1AI) has released an update.
Algorae Pharmaceuticals Ltd announces the appointment of Ms Jennifer Voon as the new Company Secretary, effective from 1 July 2024. Ms Voon brings over a decade of financial services expertise, with a special focus on capital markets and compliance, succeeding Ms Maria Clemente of Automic Group. Algorae, a company dedicated to the development of novel treatments for unmet medical needs, continues to innovate with its proprietary AI-driven drug discovery platform, AlgoraeOS.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.
